AI assistant
BIOGEN INC. — Director's Dealing 2014
Jan 6, 2014
30291_dirs_2014-01-06_77ac77c8-1dcd-4e63-857b-6f5edb38cd06.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2014-01-02
Reporting Person: SHERWIN STEPHEN A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-01-02 | Common Stock | M | 5500 | $59.82 | Acquired | 9460 | Direct |
| 2014-01-02 | Common Stock | S | 1800 | $278.836 | Disposed | 7660 | Direct |
| 2014-01-02 | Common Stock | S | 3700 | $279.501 | Disposed | 3960 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-01-02 | Stock Option (Right to Buy) | $59.82 | M | 5500 | Disposed | 2020-03-22 | Common Stock (5500) | Direct |
Footnotes
F1: Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2: This represents the weighted average price for shares sold at a range between $278.25 (low) and $279.24 (high).
F3: Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
F4: This represents the weighted average price for shares sold at a range between $279.25
(low) and $279.75 (high).
F5: The stock options become exercisable in three (3) equal annual installments commencing one year after the grant date of 03/22/2010.